ADPT
#1508
Adaptive Biotechnologies Corporation - Common Stock
25.1 9 USD
-0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.73%
Monthly Change
+13.47%
6 month change
+62.41%
Year Change
+45.94%
Previous Close
26.4 4
Open
25.1 9
Low
25.1 9
High
25.1 9
Volume
151
Financials
- Market Capitalization 4.02 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-41.64
Price to sales ratio
8.9
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1474 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 57.86 USD | -4.36% | -3.20% | +9.09% | +180.06% | 4.24 B USD | ||
| 1493 |  RLAY Relay Therapeutics, Inc. - Common Stock | 18.77 USD | -3.35% | -2.04% | +0.48% | +424.30% | 4.11 B USD | ||
| 1518 |  TNGX Tango Therapeutics, Inc. - Common Stock | 23.34 USD | -7.67% | -1.10% | -11.46% | +253.10% | 3.94 B USD | ||
| 1532 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +76.43% | +277.61% | 3.87 B USD |
Frequently asked questions about Adaptive Biotechnologies Corporation Common Stock
What is the Adaptive Biotechnologies Corporation Common Stock stock price today?
The current price of Adaptive Biotechnologies Corporation Common Stock (ADPT) is 25.19. Over the past 24 hours, the stock has changed by -4.73%. Follow the ADPT chart for real-time price dynamics.
What is the stock ticker of Adaptive Biotechnologies Corporation Common Stock?
Adaptive Biotechnologies Corporation Common Stock trades under the ticker ADPT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Adaptive Biotechnologies Corporation Common Stock stock going up?
ADPT has changed by -1.72% over the last week, +13.47% over the last month, and +45.94% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Adaptive Biotechnologies Corporation Common Stock?
Adaptive Biotechnologies Corporation Common Stock currently has a market capitalization of 4.02 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Adaptive Biotechnologies Corporation Common Stock earnings last quarter?
Last quarter, Adaptive Biotechnologies Corporation Common Stock reported earnings of -0.25 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Adaptive Biotechnologies Corporation Common Stock revenue for the last quarter?
Adaptive Biotechnologies Corporation Common Stock reported quarterly revenue of 71.55 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Adaptive Biotechnologies Corporation Common Stock net income for the last quarter?
Adaptive Biotechnologies Corporation Common Stock reported net income of -39.79 M for the last quarter. The previous quarter showed -20.03 M, which means net income changed by -98.61%.
How many employees does Adaptive Biotechnologies Corporation Common Stock have?
As of the latest available data, Adaptive Biotechnologies Corporation Common Stock has 624 employees. Workforce size can provide additional context about the company's scale and operations.
What is Adaptive Biotechnologies Corporation Common Stock EBITDA?
Adaptive Biotechnologies Corporation Common Stock EBITDA is -12.19 M, and its EBITDA margin is -17.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Adaptive Biotechnologies Corporation Common Stock stock?
You can buy Adaptive Biotechnologies Corporation Common Stock (ADPT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Adaptive Biotechnologies Corporation Common Stock stock?
Investing in Adaptive Biotechnologies Corporation Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADPT chart and related analysis on metatrader.com as part of your research.